日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma

Selinexor(一种首创的核输出抑制剂)治疗晚期难治性骨或软组织肉瘤患者的 IB 期研究

Gounder, Mrinal M; Zer, Alona; Tap, William D; Salah, Samer; Dickson, Mark A; Gupta, Abha A; Keohan, Mary Louise; Loong, Herbert H; D'Angelo, Sandra P; Baker, Stephanie; Condy, Mercedes; Nyquist-Schultz, Kjirsten; Tanner, Lanier; Erinjeri, Joseph P; Jasmine, Francis H; Friedlander, Sharon; Carlson, Robert; Unger, Thaddeus J; Saint-Martin, Jean-Richard; Rashal, Tami; Ellis, Joel; Kauffman, Michael; Shacham, Sharon; Schwartz, Gary K; Abdul Razak, Albiruni Ryan